Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Branford

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Blood|November 25, 2021
Taming the gatekeeper: ponatinib dose holds the keySusan Branford
British Journal of Haematology|February 3, 2022
BCR::ABL1 transcripts and clinical outcome - interrogating the techniqueSusan Branford
Hematology. American Society of Hematology. Education Program|November 21, 2007
Chronic myeloid leukemia: molecular monitoring in clinical practiceSusan Branford
Hematology. American Society of Hematology. Education Program|December 13, 2012
Monitoring after successful therapy for chronic myeloid leukemiaSusan Branford
Hematology. American Society of Hematology. Education Program|December 4, 2016
Molecular monitoring in chronic myeloid leukemia-how low can you go?Susan Branford
Haematologica|October 15, 2020
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?Susan Branford
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 14, 2022
Initial Rate of <i>BCR::ABL1</i> Decline for Response Prediction in Chronic Myeloid LeukemiaSusan Branford
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Continued therapeutic response monitoring in optimal responders with CMLSusan Branford
Best Practice & Research. Clinical Haematology|November 15, 2016
Monitoring and defining early response: Where to draw the line?Susan Branford
Hemasphere|March 21, 2022
NGS in CML - New standard diagnostic procedure?Susan Branford, Naranie Shanmuganathan
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Blood|November 25, 2021
Taming the gatekeeper: ponatinib dose holds the keySusan Branford
British Journal of Haematology|February 3, 2022
BCR::ABL1 transcripts and clinical outcome - interrogating the techniqueSusan Branford
Hematology. American Society of Hematology. Education Program|November 21, 2007
Chronic myeloid leukemia: molecular monitoring in clinical practiceSusan Branford
Hematology. American Society of Hematology. Education Program|December 13, 2012
Monitoring after successful therapy for chronic myeloid leukemiaSusan Branford
Hematology. American Society of Hematology. Education Program|December 4, 2016
Molecular monitoring in chronic myeloid leukemia-how low can you go?Susan Branford
Haematologica|October 15, 2020
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?Susan Branford
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 14, 2022
Initial Rate of <i>BCR::ABL1</i> Decline for Response Prediction in Chronic Myeloid LeukemiaSusan Branford
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Continued therapeutic response monitoring in optimal responders with CMLSusan Branford
Best Practice & Research. Clinical Haematology|November 15, 2016
Monitoring and defining early response: Where to draw the line?Susan Branford
Hemasphere|March 21, 2022
NGS in CML - New standard diagnostic procedure?Susan Branford, Naranie Shanmuganathan
Pageof 14